The potential antiarrhythmic properties of sacubitril/valsartan: a case report

J Cardiovasc Med (Hagerstown). 2019 Nov;20(11):780-782. doi: 10.2459/JCM.0000000000000808.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aminobutyrates / therapeutic use*
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / diagnostic imaging
  • Arrhythmias, Cardiac / drug therapy*
  • Arrhythmias, Cardiac / physiopathology
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Heart Rate / drug effects*
  • Humans
  • Male
  • Neprilysin / antagonists & inhibitors
  • Protease Inhibitors / therapeutic use*
  • Recovery of Function
  • Tetrazoles / therapeutic use*
  • Treatment Outcome
  • Valsartan
  • Ventricular Function, Left / drug effects

Substances

  • Aminobutyrates
  • Angiotensin II Type 1 Receptor Blockers
  • Anti-Arrhythmia Agents
  • Biphenyl Compounds
  • Drug Combinations
  • Protease Inhibitors
  • Tetrazoles
  • Valsartan
  • Neprilysin
  • sacubitril and valsartan sodium hydrate drug combination